Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for iHuman (IH) over the last 6 years, with Q3 2025 value amounting to $516.3 billion.

  • iHuman's Cash & Equivalents changed N/A to $516.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $516.3 billion, marking a year-over-year change of. This contributed to the annual value of $1123.3 billion for FY2024, which is 745.41% down from last year.
  • iHuman's Cash & Equivalents amounted to $516.3 billion in Q3 2025.
  • Over the past 5 years, iHuman's Cash & Equivalents peaked at $1119.1 billion during Q1 2025, and registered a low of $124.6 million during Q1 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $168.6 million (2023), whereas its average is $375.1 billion.
  • In the last 5 years, iHuman's Cash & Equivalents plummeted by 723.53% in 2024 and then soared by 89820017.52% in 2025.
  • iHuman's Cash & Equivalents (Quarter) stood at $133.8 million in 2021, then increased by 10.35% to $147.6 million in 2022, then increased by 14.19% to $168.6 million in 2023, then decreased by 7.24% to $156.4 million in 2024, then surged by 330067.13% to $516.3 billion in 2025.
  • Its last three reported values are $516.3 billion in Q3 2025, $605.1 billion for Q2 2025, and $1119.1 billion during Q1 2025.